UBS AM’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

UBS AM’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-43,503	Closed	-$4.38M	–	2682
2014 Q4	$4.38M	Sell	43,503 -168,800	-80%	-$13.1M	﹤0.01%	1068
2014 Q3	$14.1M	Buy	212,303 +8,200	+4%	+$539K	0.01%	760
2014 Q2	$14.3M	Sell	204,103 -11,892	-6%	-$809K	0.01%	762
2014 Q1	$15.8M	Buy	215,995 +50,486	+31%	+$3.76M	0.02%	719
2013 Q4	$11.4M	Sell	165,509 -21,587	-12%	-$1.4M	0.01%	794
2013 Q3	$11.9M	Sell	187,096 -300,182	-62%	-$18.1M	0.01%	752
2013 Q2	$23.5M	Buy	+487,278	New	+$23.9M	0.03%	522

UBS AM's CBST Position: Q1 2015 in Review

UBS AM sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 43,503 shares — an estimated $4.38M sold.

UBS AM first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $23.5M in Q2 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

UBS AM reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
UBS AM sold 43,503 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $4.38M.
UBS AM first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
UBS AM's CUBIST PHARMACEUTICALS INC position peaked at $23.5M in Q2 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.